Pfizer to launch an innovative anti-fungal drug.

Published: 2005-09-06 06:59:00

Updated: 2005-09-06 06:59:00

Pfizer Korea has launched an innovative anti-fungal drug, "V-fend" (voriconazole) in tablet and injectable dosage form especially for the treatment of severe fungal infections such as invasive aspergillosis and candidasis, the adjuvant medication of hemoblast and liver implant and cancer chemotherapy or the prevention of critical fungal infections for AIDS patients.

V-fend showed 53% therap...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.